|
Volumn 88, Issue 8, 1996, Pages 486-488
|
Cancer vaccines, disappointing in the past, show promise
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 DINITROPHENOL;
BCG VACCINE;
CANCER VACCINE;
GLYCOLIPID;
IMMUNOLOGICAL ADJUVANT;
KEYHOLE LIMPET HEMOCYANIN;
PHOSPHORYL LIPID A;
QS 21;
CANCER;
CANCER IMMUNOLOGY;
CANCER IMMUNOTHERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG FORMULATION;
HUMAN;
MELANOMA;
METASTASIS;
NONHUMAN;
NOTE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
TREATMENT OUTCOME;
VACCINE PRODUCTION;
HUMANS;
NEOPLASMS;
QUALITY OF LIFE;
VACCINES;
|
EID: 0029926674
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/88.8.486 Document Type: Note |
Times cited : (3)
|
References (0)
|